Yulia Ron

2.0k total citations
47 papers, 1.1k citations indexed

About

Yulia Ron is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Yulia Ron has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Genetics, 21 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Yulia Ron's work include Inflammatory Bowel Disease (32 papers), Microscopic Colitis (18 papers) and Eosinophilic Esophagitis (11 papers). Yulia Ron is often cited by papers focused on Inflammatory Bowel Disease (32 papers), Microscopic Colitis (18 papers) and Eosinophilic Esophagitis (11 papers). Yulia Ron collaborates with scholars based in Israel, Italy and United Kingdom. Yulia Ron's co-authors include Iris Dotan, Henit Yanai, Shomron Ben‐Horin, Yehuda Chowers, Lev Lichtenstein, Uri Kopylov, Batia Weiss, Rami Eliakim, Gerald Fraser and Sigal Fishman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Yulia Ron

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yulia Ron Israel	14	793	600	411	273	136	47	1.1k
Jeroen M. Jansen Netherlands	19	1.2k 1.6×	944 1.6×	442 1.1×	362 1.3×	85 0.6×	48	1.5k
Paul Pollack United States	10	1.4k 1.7×	1.1k 1.8×	490 1.2×	440 1.6×	93 0.7×	29	1.7k
Vincent Billioud France	11	1.0k 1.3×	789 1.3×	227 0.6×	426 1.6×	86 0.6×	14	1.3k
Michael Smyth United Kingdom	14	816 1.0×	650 1.1×	261 0.6×	256 0.9×	70 0.5×	43	1.1k
Iván Guerra Spain	20	470 0.6×	281 0.5×	192 0.5×	364 1.3×	71 0.5×	73	1.0k
Virginia Solitano Italy	16	540 0.7×	344 0.6×	166 0.4×	202 0.7×	61 0.4×	84	774
Sara Onali Italy	26	1.1k 1.3×	709 1.2×	269 0.7×	514 1.9×	116 0.9×	68	1.5k
Ayanna Lewis United States	4	1.3k 1.7×	998 1.7×	179 0.4×	552 2.0×	174 1.3×	10	1.5k
Alicia Algaba Spain	20	699 0.9×	491 0.8×	244 0.6×	480 1.8×	89 0.7×	68	1.3k
Kathleen G. Lomax United States	17	1.6k 2.0×	1.3k 2.2×	342 0.8×	660 2.4×	132 1.0×	59	2.0k

Countries citing papers authored by Yulia Ron

Since Specialization

Citations

This map shows the geographic impact of Yulia Ron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulia Ron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulia Ron more than expected).

Fields of papers citing papers by Yulia Ron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulia Ron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulia Ron. The network helps show where Yulia Ron may publish in the future.

Co-authorship network of co-authors of Yulia Ron

This figure shows the co-authorship network connecting the top 25 collaborators of Yulia Ron. A scholar is included among the top collaborators of Yulia Ron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulia Ron. Yulia Ron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sarbagili‐Shabat, Chen, Shira Zelber‐Sagi, Ayal Hirsch, et al.. (2025). High Ultra-Processed Food Consumption Is Associated with Clinical Exacerbation in Patients with Crohn’s Disease in Remission: A Prospective Cohort Study. Digestive Diseases. 43(4). 466–475. 2 indexed citations

Meir, Y. J., Haim Leibovitzh, Ayal Hirsch, et al.. (2025). Effectiveness of the Crohn’s Disease Exclusion Diet for the Treatment of Crohn’s Disease in the Older-Adult Population: Real-World Experience. Digestive Diseases. 44(1). 33–41.

Werner, Lael, et al.. (2024). P867 Abdominally targeted yoga-based physical exercises as a therapeutic intervention for Inflammatory Bowel Diseases. Journal of Crohn s and Colitis. 18(Supplement_1). i1594–i1594. 1 indexed citations

Leibovitzh, Haim, Chen Sarbagili‐Shabat, Ayal Hirsch, et al.. (2024). P1203 Fecal transplantation for Ulcerative Colitis from diet conditioned donors followed by dietary intervention results in favorable gut microbial profile and decreased gut inflammation compared to fecal transplantation alone. Journal of Crohn s and Colitis. 18(Supplement_1). i2128–i2128. 2 indexed citations

Sarbagili‐Shabat, Chen, Shira Zelber‐Sagi, Naomi Fliss‐Isakov, et al.. (2024). Ultra-Processed Foods Consumption Is Positively Associated with the Clinical Activity of Inflammatory Bowel Diseases: A Cross-Sectional Single-Center Study. Inflammatory Intestinal Diseases. 9(1). 241–251. 7 indexed citations

Cohen, Nathaniel A., Ayal Hirsch, Yulia Ron, et al.. (2024). P891 Comparative Effectiveness and Safety of Infliximab and Tacrolimus in the Treatment of Acute Severe Ulcerative Colitis. Journal of Crohn s and Colitis. 18(Supplement_1). i1628–i1629. 1 indexed citations

Fliss‐Isakov, Naomi, Nathaniel A. Cohen, Ronit Anbar, et al.. (2023). Crohn’s Disease Exclusion Diet for the Treatment of Crohn’s Disease: Real-World Experience from a Tertiary Center. Journal of Clinical Medicine. 12(16). 5428–5428. 10 indexed citations

Hirsch, Ayal, Erez Scapa, Naomi Fliss‐Isakov, et al.. (2023). Early Initiation of Adalimumab Significantly Diminishes Postoperative Crohn’s Disease Endoscopic Recurrence and Is Superior to 6-Mercaptopurine Therapy: An Open-Label, Randomized Controlled Study. Journal of Clinical Medicine. 12(24). 7600–7600. 5 indexed citations

Avni‐Biron, Irit, Eran Zittan, Uri Kopylov, et al.. (2022). Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study. Alimentary Pharmacology & Therapeutics. 56(9). 1361–1369. 24 indexed citations

10.

Weiss, Batia, Shomron Ben‐Horin, Atar Lev, et al.. (2022). Immune function in newborns with in-utero exposure to anti-TNFα therapy. Frontiers in Pediatrics. 10. 935034–935034. 13 indexed citations

11.

Hirsch, Ayal, et al.. (2020). Higher Maintenance Adalimumab Trough Levels are Associated With Achievement of Advanced Remission Targets in Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 55(9). 810–814. 4 indexed citations

12.

Sarbagili‐Shabat, Chen, Shira Zelber‐Sagi, Naomi Fliss‐Isakov, et al.. (2020). Development and validation of processed foods questionnaire (PFQ) in adult inflammatory bowel diseases patients. European Journal of Clinical Nutrition. 74(12). 1653–1660. 11 indexed citations

13.

Cohen, Nathaniel A., Nikolas Plevris, Uri Kopylov, et al.. (2020). Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study. United European Gastroenterology Journal. 8(9). 1076–1085. 32 indexed citations

14.

Bentur, Ohad S., Eldad J. Dann, Esther Paran, et al.. (2019). Interim PET-CT–guided therapy in elderly patients with Hodgkin lymphoma—a retrospective national multi-center study. Annals of Hematology. 98(7). 1665–1674. 5 indexed citations

15.

Kopylov, Uri, Irit Avni‐Biron, Yulia Ron, et al.. (2018). Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience. Digestive and Liver Disease. 51(1). 68–74. 21 indexed citations

16.

Yanai, Henit, Yulia Ron, Guy Rosner, et al.. (2017). Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic Strategies. Digestion. 96(3). 135–141. 4 indexed citations

17.

Kopylov, Uri, Yulia Ron, Irit Avni‐Biron, et al.. (2017). Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience. Inflammatory Bowel Diseases. 23(3). 404–408. 82 indexed citations

18.

Dotan, Iris, Yulia Ron, Henit Yanai, et al.. (2014). Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 20(12). 2247–2259. 224 indexed citations

19.

Yanai, Henit, Lev Lichtenstein, Amit Assa, et al.. (2014). Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab. Clinical Gastroenterology and Hepatology. 13(3). 522–530.e2. 236 indexed citations

20.

Hod, Keren, Ram Dickman, Ami D. Sperber, et al.. (2011). Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome. Neurogastroenterology & Motility. 23(12). 1105–1110. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact